References

1. 1.
   BRAY F，LAVERSANNE M，SUNG H，et al.Global cancer statistics 2022：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2024，74（3）：229-263.
2. 2.
   MULLARD A.Addressing cancer's grand challenges［J］.Nat Rev Drug Discov，2020，19（12）：825-826.
3. 3.
   LIU X Y，CHEN Y J，ZHANG S，et al.Gut microbiota-mediated immunomodulation in tumor［J］.J Exp Clin Cancer Res，2021，40（1）：221.
4. 4.
   LIAO Y，WEN Y P，LIU L S.Intervention of lung cancer by Chinese medicine and active components via affecting gut microbiota：A review［J］.Chin J Exp Tradit Med Form，2023，29（24）：194-201.
5. 5.
   LUO C，YE Y H，ZHENG L，et al.Research progress of traditional Chinese medicine based on "lung-intestinal" axis regulating intestinal flora in the treatment of severe pneumonia［J］.China Med Herald，2023，20（6）：33-36.
6. 6.
   LUO C ，YE Y H，SHENG G G，et al.Research progress of Xuanbai Chengqi decoction and its additive prescription in the treatment of respiratory diseases［J］.Chin Tradit Pat Med，2023，45（10）：3369-3375.
7. 7.
   PARK E M，CHELVANAMBI M，BHUTIANI N，et al.Targeting the gut and tumor microbiota in cancer［J］.Nat Med，2022，28（4）：690-703.
8. 8.
   SIMPSON R C，SHANAHAN E R，SCOLYER R A，et al.Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors［J］.Nat Rev Clin Oncol，2023，20（10）：697-715.
9. 9.
   ZHOU C B，ZHOU Y L，FANG J Y.Gut microbiota in cancer immune response and immunotherapy［J］.Trends Cancer，2021，7（7）：647-660.
10. 10.
    SHAH S C，ITZKOWITZ S H.Colorectal cancer in inflammatory bowel disease：Mechanisms and management［J］.Gastroenterology，2022，162（3）：715-730.
11. 11.
    LUO C，YE Y H，KE J.Effect of inflammation on lung cancer based on theory of "Zhuang Huo Shi Qi"［J］.Acta Chin Med，2024，39（4）：689-694.
12. 12.
    LUO C，YE Y H，KE J.Exploring the lung "inflammation and cancer transformation" and prevention ideas based on the theory of "Zhuang Huo Shi Qi"［J］.J Sichuan Tradit Chin Med，2024，42（3）：61-64.
13. 13.
    ZOU Y Q，WANG S L，ZHANG H H，et al.The triangular relationship between traditional Chinese medicines，intestinal flora，and colorectal cancer［J］.Med Res Rev，2024，44（2）：539-567.
14. 14.
    FENG X L，LI Z H，GUO W H，et al.The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation：A review［J］.Front Immunol，2023，14：1087755.
15. 15.
    HUANG M G，XIE S，WANG J X，et al.Chinese medicine in treatment of ulcerative colitis by regulating intestinal flora：A review［J］.Chin J Exp Tradit Med Form，2024，30（2）：267-275.
16. 16.
    GAO R Y，WU C Y，ZHU Y F，et al.Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites［J］.Gastroenterology，2022，163（4）：1024-1037.
17. 17.
    BAI X W，WEI H，LIU W X，et al.Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites［J］.Gut，2022，71（12）：2439-2450.
18. 18.
    YACHIDA S，MIZUTANI S，SHIROMA H，et al.Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer［J］.Nat Med，2019，25（6）：968-976.
19. 19.
    BERTOCCHI A，CARLONI S，RAVENDA P S，et al.Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver［J］.Cancer Cell，2021，39（5）：708-724.
20. 20.
    DZIUBAŃSKA-KUSIBAB P J，BERGER H，BATTISTINI F，et al.Colibactin DNA-damage signature indicates mutational impact in colorectal cancer［J］.Nat Med，2020，26（7）：1063-1069.
21. 21.
    WONG C C，YU J.Gut microbiota in colorectal cancer development and therapy［J］.Nat Rev Clin Oncol，2023，20（7）：429-452.
22. 22.
    GALEANO NIÑO J L，WU H R，LACOURSE K D，et al.Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer［J］.Nature，2022，611（7937）：810-817.
23. 23.
    SINGH N，GURAV A，SIVAPRAKASAM S，et al.Activation of Gpr109a，receptor for niacin and the commensal metabolite butyrate，suppresses colonic inflammation and carcinogenesis［J］.Immunity，2014，40（1）：128-139.
24. 24.
    CREMONESI E，GOVERNA V，GARZON J F G，et al.Gut microbiota modulate T cell trafficking into human colorectal cancer［J］.Gut，2018，67（11）：1984-1994.
25. 25.
    SECHER T，NORMAND S，CHAMAILLARD M.NOD2 prevents emergence of disease-predisposing microbiota［J］.Gut Microbes，2013，4（4）：353-356.
26. 26.
    ZHU H B，XU W Y，HU Z Q，et al.RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer［J］.J Exp Clin Cancer Res，2017，36（1）：2.
27. 27.
    KESSELRING R，GLAESNER J，HIERGEIST A，et al.IRAK-M expression in tumor cells supports colorectal cancer progression through reduction of antimicrobial defense and stabilization of STAT3［J］.Cancer Cell，2016，29（5）：684-696.
28. 28.
    MAN S M，ZHU Q F，ZHU L Q，et al.Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer［J］.Cell，2015，162（1）：45-58.
29. 29.
    ZHANG X Y，ZHAO S W，SONG X B，et al.Inhibition effect of Glycyrrhiza polysaccharide （GCP） on tumor growth through regulation of the gut microbiota composition［J］.J Pharmacol Sci，2018，137（4）：324-332.
30. 30.
    SUN Q，YANG H，LIU M L，et al.Berberine suppresses colorectal cancer by regulation of Hedgehog signaling pathway activity and gut microbiota［J］.Phytomedicine，2022，103：154227.
31. 31.
    CHEN H T，YE C X，WU C H，et al.Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine［J］.Int J Biol Sci，2023，19（7）：2097-2113.
32. 32.
    ZHU L Q，ZHANG L，ZHANG J，et al.Evodiamine inhibits high-fat diet-induced colitis-associated cancer in mice through regulating the gut microbiota［J］.J Integr Med，2021，19（1）：56-65.
33. 33.
    WEI J，ZHENG Z M，HOU X X，et al.Baicalin modulates gut microbiota and inhibits liver metastasis of colorectal cancer induced by high-fat diet［J］.Shanghai J Tradit Chin Med，2023，57（10）：59-67.
34. 34.
    GUO C L，GUO D D，FANG L，et al.Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon［J］.Carbohydr Polym，2021，267：118231.
35. 35.
    GOU H Y，SU H，LIU D H，et al.Traditional medicine pien tze Huang suppresses colorectal tumorigenesis through restoring gut microbiota and metabolites［J］.Gastroenterology，2023，165（6）：1404-1419.
36. 36.
    ZHANG Z Z，SHAO S Y，ZHANG Y R，et al.Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts［J］.Biomed Pharmacother，2020，132：110916.
37. 37.
    SUI H，ZHANG L，GU K J，et al.YYFZBJS ameliorates colorectal cancer progression in Apc^Min/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation［J］.Cell Commun Signal，2020，18（1）：113.
38. 38.
    LYU J，JIA Y T，LI J，et al.Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment［J］.Cell Death Dis，2019，10（6）：415.
39. 39.
    YE C X，WU C H，LI Y，et al.Traditional medicine Xianglian pill suppresses high-fat diet-related colorectal cancer via inactivating TLR4/MyD88 by remodeling gut microbiota composition and bile acid metabolism［J］.J Ethnopharmacol，2024，333：118411.
40. 40.
    RAY K.Gut microbiota：Obesity-induced microbial metabolite promotes HCC［J］.Nat Rev Gastroenterol Hepatol，2013，10（8）：442.
41. 41.
    SCHNABL B，BRENNER D A.Interactions between the intestinal microbiome and liver diseases［J］.Gastroenterology，2014，146（6）：1513-1524.
42. 42.
    ZHOU Y，HU L，TANG W Q，et al. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism［J］.J Hematol Oncol，2021，14（1）：9.
43. 43.
    QIN N，YANG F L，LI A，et al.Alterations of the human gut microbiome in liver cirrhosis［J］.Nature，2014，513（7516）：59-64.
44. 44.
    YU L X，YAN H X，LIU Q，et al.Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents［J］.Hepatology，2010，52（4）：1322-1333.
45. 45.
    DAPITO D H，MENCIN A，GWAK G Y，et al.Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4［J］.Cancer Cell，2012，21（4）：504-516.
46. 46.
    SCHWABE R F，GRETEN T F.Gut microbiome in HCC—Mechanisms，diagnosis and therapy［J］.J Hepatol，2020，72（2）：230-238.
47. 47.
    PONZIANI F R，BHOORI S，CASTELLI C，et al.Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease［J］.Hepatology，2019，69（1）：107-120.
48. 48.
    ZHANG X，COKER O O，CHU E S，et al.Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites［J］.Gut，2021，70（4）：761-774.
49. 49.
    FENG D，WANG J，JIANG Y J，et al.Effects of total glycosides of Cistanche deserticola on HepG2 hepatoma-bearing mice［J］.Food Sci，2024，45（6）：120-129.
50. 50.
    TIAN L，WAN D J，WEN Y M.Effect of salvianolic acid B on TLR4/MyD88/NF-κB pathway and intestinal bacteria in H22 tumor-bearing mice［J］.World Sci Technol Mod Tradit Chin Med Mater Med，2023，25（5）：1871-1878.
51. 51.
    YU L，SUN C，ZHANG M X.Regulation of intestinal floras and their metabolism functions by Ganoderma lucidum plysaceharide in mice with HepG₂ cell-induced implanted cancer［J］.J Pract Hepatol，2021，24（4）：476-479
52. 52.
    TIAN L，WAN D J，QIU D Y，et al.Effect of ursolic acid on anti-tumor and intestinal bacterial community structure and diversity in H22 tumor-bearing mice［J］.Sci Technol Food Ind，2021，42（4）：86-91.
53. 53.
    HAN D D，HU M F，YU C.Effect of Diwu Yanggan decoction on intestinal flora in liver cancer model through regulating TLR4/NF-κB signal pathway［J］.J Liaoning Univ Tradit Chin Med，2023，25（11）：68-72.
54. 54.
    ZHANG Y M，ZHU L，SHI J，et al.Effects of Yinchenhao decoction on hepatic bile acid and intestinal microecology in mice with orthotopic transplantation of hepatocellular carcinoma［J］.Guangming J Chin Med，2022，37（16）：2939-2942.
55. 55.
    LI S S，PU W Y，LING Y，et al.Sanwubai powder reversing Th1/Th2 drift by affecting FXR expression and exerting anti-liver cancer immune response［J］.Acta Chin Med，2021，36（5）：1021-1028
56. 56.
    GUO Q Q，QIN H，LIU X L，et al.The emerging roles of human gut microbiota in gastrointestinal cancer［J］.Front Immunol，2022，13：915047.
57. 57.
    ZHANG W，ZHOU Y N，FAN Y T，et al.Metal-organic-framework-based hydrogen-release platform for multieffective Helicobacter pylori targeting therapy and intestinal flora protective capabilities［J］.Adv Mater，2022，34（2）：e2105738.
58. 58.
    FERREIRA R M，PEREIRA-MARQUES J，PINTO-RIBEIRO I，et al.Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota［J］.Gut，2018，67（2）：226-236.
59. 59.
    GUO Y，ZHANG Y，GERHARD M，et al.Effect of Helicobacter pylori on gastrointestinal microbiota：A population-based study in Linqu，a high-risk area of gastric cancer［J］.Gut，2020，69（9）：1598-1607.
60. 60.
    LI T H，QIN Y W，SHAM P C，et al.Alterations in gastric microbiota after H. pylori eradication and in different histological stages of gastric carcinogenesis［J］.Sci Rep，2017，7（1/4）：44935.
61. 61.
    SUNG J J Y，COKER O O，CHU E，et al.Gastric microbes associated with gastric inflammation，atrophy and intestinal Metaplasia 1 year after Helicobacter pylori eradication［J］.Gut，2020，69（9）：1572-1580.
62. 62.
    FU K L，CHEUNG A H K，WONG C C，et al.Streptococcus anginosus promotes gastric inflammation，atrophy，and tumorigenesis in mice［J］.Cell，2024，187（4）：882-896.
63. 63.
    LI Q，WU W，GONG D X，et al.Correction to：Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling［J］.Gastric Cancer，2022，25（6）：1139-1141.
64. 64.
    DENG R，YU S Y，RUAN X Q，et al.Capsaicin orchestrates metastasis in gastric cancer via modulating expression of TRPV1 channels and driving gut microbiota disorder［J］.Cell Commun Signal，2023，21（1）：364.
65. 65.
    BAI X，CHENG F E，YANG C Y，et al.Mechanism of Eremias multiocellata on inhibiting gastric cancer with liver metastasis based on SNAIL signaling pathway and gut microbiota［J］.Chin Tradit Herb Drugs，2023，54（3）：825-833.
66. 66.
    ZHANG Y，LU F G，SONG P H，et al.Effect of ursolic acid on tumor inhibition and intestinal flora of mice transplanted with SCG-7901 tumor cells［J］.Anat Res，2021，43（3）：199-205.
67. 67.
    CHEN Y L，CHEN X，ZHANG R J，et al.Study on the effect of modified Buzhong Yiqi prescription on intestinal flora of gastric tumor carrying mice based on 16S rRNA high-throughput sequencing technology［J］.Jiangsu J Tradit Chin Med，2022，54（8）：70-75.
68. 68.
    BIAN Y Q，CHEN X，CAO H Y，et al.A correlational study of Weifuchun and its clinical effect on intestinal flora in precancerous lesions of gastric cancer［J］.Chin Med，2021，16（1）：120.
69. 69.
    ZHAO T T，YU Z J.Modified Gexia-Zhuyu Tang inhibits gastric cancer progression by restoring gut microbiota and regulating pyroptosis［J］.Cancer Cell Int，2024，24（1）：21.